Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Voxtur is the Leading Provider of Digital, SaaS Solutions for Real Estate Transactions in N. America

Before we dive into what makes Voxtur Analytics ( TSX-V: VXTR ; OTCQB: VXTRF) a standout PropTech company (and an undervalued investment opportunity), it’s worth highlighting a few recent developments: –Voxtur has seen revenues increase 300% year-over-year a...
Stockhouse Editorial | September 22, 2021 |

Buzz on the Bullboards: Markets React to Uncertainty Over US Election Outcome

(Screenshots via CNN video.) It has been a tumultuous time for the markets, from abrupt deep dips to relief rallies that saw effects to indexes on both sides of the border. US stock futures have been northing short of volatile in the last few days with the president...
Stockhouse Editorial | November 4, 2020 |

A Minsky Moment is coming for gold

“Minsky Moment” refers to the idea that periods of bullish speculation will eventually lead to a crisis, wherein a sudden decline in optimism causes a spectacular market crash. Named after economist Hyman Minsky, the theory centers around the inheren...
Richard (Rick) Mills | February 21, 2020 |

Disruptive Technology Poised to Deliver Significant Advancement in Bladder Cancer Detection

Chris Temple, editor and publisher of The National Investor, explains why he recommends this small-cap as a Buy. Imagin Medical's disruptive technology is poised to deliver the most significant advancement in bladder cancer detection and removal in decades , ma...
Streetwise Reports | January 15, 2020 |

The Optimist’s Guide to Airlines and Gold

“Travel,” Mahatma Gandhi once said, “is the language of peace.” If that’s the case—and I happen to believe that it is—then I’m extremely bullish about the future, especially with respect to ...
Frank Holmes | October 15, 2019 |

US Markets “Roll Over” On Earnings and Economic Data At Channel Highs

As we near the end of October 2019, a very interesting price setup is taking place across many of the US market sectors recently. We only have a total of about seven trading days left in October 2019 and the Financial Sector ETF is rolling over with what appears to be an Engul...
Chris Vermeulen | October 23, 2019 |

Fed Panics over Coronavirus. What’s Next for Gold?

Yesterday, the Fed cut interest rates by 50 basis points. Not during a regular monetary policy meeting, but in a surprising move. But what are the implications for the gold market specifically? Fed Cuts Interest Rates in Emergency Move Last week, I wrote that the spread...
Arkadiusz Sieron | March 4, 2020 |

Does Gold Really Care Whether Coronavirus Brings Us Deflation or Inflation?

One of the many bothering issues about the coronavirus crisis, is whether it will turn out to be inflationary or deflationary. What do both of these scenarios mean for gold ahead? US Inflation Rate Declines in March Many people are afraid that the coronavirus crisis wi...
Arkadiusz Sieron | April 16, 2020 |

Fate Therapeutics Shares Rise 10% as First Person Treated with Its Anti-Cancer Therapy

Shares of Fate Therapeutics traded higher after the firm reported it has treated the first patient in a first-in-human trial of FT596 for patients with B-cell malignancies and chronic lymphocytic leukemia. Clinical-stage biopharmaceutical company Fate Thera...
Streetwise Reports | April 7, 2020 |

Announcement of Binding Agreement on Salar de Arizaro, Argentina & Company

Lithium Chile: Announcement of Binding Agreement on Salar de Arizaro, Argentina & Company On Monday, Lithium Chile announced a very exciting addition to its Lithium Portfolio. This new property gives the company location diversification and an expedited timetable to fe...
Featured Submission | May 28, 2021 |
1 2 3 4 5 6 7 8